Solid Dosage
Anti-virals
GEA supplies solutions for manufacturing inhalable and oral antiviral drugs ranging from blending, spray drying and particle engineering to continuous manufacturing.
Manufacturing Anti-virals
Antiviral medications help the body to fight off harmful viruses such as influenza, chickenpox and the human immunodeficiency virus (HIV), to name a few. The drugs can ease symptoms and shorten the length of a viral infection. Antivirals also lower the risk of getting or spreading viruses that cause herpes and HIV. One approved antiviral treats the coronavirus that causes COVID-19.
Antiviral drugs are also preventive. They can protect you from getting viral infections or spreading a virus to others. They come in many formats, including tablets, intravenous solutions, liquids and inhaled powders.
For inhalable versions, GEA understands that homogeneity and stability are key factors. Our dry powder blending, spray drying and particle engineering capabilities ensure that the production of free-flowing, aerodynamic particles at the correct size is achievable at the scale you need.
And, with the ongoing development of oral anti-viral medications, particularly as a result of the COVID-19, pandemic, there is increased interest in the use of continuous manufacturing to accelerate process design and product optimization.
For example, the compact and fully integrated ConsiGma®4.0 platform has been designed to transfer powder into coated tablets in a shorter time frame. Plus, by combining Quality by Design (QbD) principles with Design of Experiments (DoE), it enables operators to explore the design space in a quick and easy way and expedite time-to-market.
Produtos e Tecnologias
Mostrando 4 de 26
Automação de Processo
Como integradores de sistema, trazemos nosso conhecimento de tecnologia de processo e engenharia de planta, juntamente com produtos de software de líderes de mercado.
Contained Materials Handling Systems
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
Continuous Direct Compression Line
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Granulation Lines
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
Downloads
Insights da GEA
Alimentando o futuro: O poder da inovação na liofilização
A redução do desperdício é importante para nós na GEA e, ao aproveitar o poder da tecnologia de liofilização, podemos transformar o excedente de alimentos em produtos valiosos e duradouros - ajudando a reduzir o desperdício, a estender a vida útil e a construir uma oferta alimentar mais resiliente para as próximas gerações.
A GEA e a Pulmuone homenageiam gerações de produção artesanal do noodle frio
Quando o fabricante de alimentos sul-coreano Pulmuone trouxe à GEA o desafio de desenvolver uma versão moderna do tradicional noodle frio elástico (naengmyeon), os especialistas em P&D da GEA estiveram à altura do desafio. Eles ajudaram a desenvolver o que hoje é um sucesso comercial produzido com menos água e eletricidade do que os métodos já existentes. O resultado também é fiel às origens tradicionais do prato, bem como às bases de saúde, bem-estar e sustentabilidade da Pulmuone.
